Navigation Links
Falcon Genomics Awarded Patent for Innovative Cancer Test
Date:5/28/2009

Patent Covers High-throughput, Anchorage-independent Assay for Screening Compounds for Inhibition of Cancer Cell Growth.

PITTSBURGH, May 28 /PRNewswire/ -- Falcon Genomics, Inc. announced today that it has received U.S. Patent # 7,537,913 with claims covering the Company's Cancer BioChip System (CBCS) for the identification and validation of potential cancer targets in a high-throughput in vitro setting with great clinical translational potential.

The patent claims are supported by experimental validation with human breast cancer cells using Falcon Genomics' first-generation Cancer BioChip System (CBC-1). These results, recently presented at the 6th Annual Conference on Cancer Drugs Research and Development in Philadelphia, PA (February 19, 2009) represent the first reported use of high-throughput one-step delivery of silencing RNA (siRNA) into cells growing in an anchorage-independent manner with real-time evaluation of cell growth.

"Cancer is analogous to a physiological train-wreck. It only takes a small number of defective signals to trigger the multitudes of abnormal molecular profiles observed within cancer cells. Triggering molecules are the ones that must be targeted for therapy," said Dr. Rula Abbud-Antaki, President and Chief Scientific Officer of Falcon Genomics. "Our proprietary technology will provide personalized identification of cancer- initiating events, and formulation of efficient and accurate therapies."

According to Dr. Peter D. Mlynek, a patent attorney with the law firm of Eckert Seamans, the Cancer BioChip System is a unique and highly useful technology. "The U.S. Patent Office has found the claimed CBCS to be novel and non-obvious."

About Falcon Genomics, Inc.

Falcon Genomics, Inc. is a private Pittsburgh-based biotech company founded in August 2004. The goal of the company is to provide cutting edge technologies, including functional genomics, for the accurate diagnosis of cancer patients and the personalized formulation of therapeutic strategies. Falcon Genomics currently provides CBCS services for research and pharmaceutical institutions working at the forefront of cancer diagnostics and therapeutics.

For more information, please visit: www.falcongenomics.com


'/>"/>
SOURCE Falcon Genomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
2. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
3. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
4. MessageSolution and FalconStor Deliver Turnkey Solution for Enterprise Archiving, DR, and High-Availability
5. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
6. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
7. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. NeoGenomics Announces Results for the 3rd Quarter 2007
10. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
11. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... , ... February 06, 2016 , ... With the ... add warm color grades to their footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. By manipulating each pixel, LUT's can ...
(Date:2/5/2016)... ... ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon on ... This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped to ... , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap on ...
(Date:2/5/2016)... & Salt Lake City, UT (PRWEB) , ... February 05, 2016 ... ... of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi ... New Really Cool Humans Amateur TV Network. , Each week, on his weekly Whole-Food ...
(Date:2/5/2016)... FL (PRWEB) , ... February 05, 2016 , ... ... the largest domestic franchisees of Popeyes Louisiana Kitchen restaurants, launched the 14th annual ... awareness for kids and adults with muscular dystrophy, ALS and related diseases that ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe A. ... a joint enrollment and degree completion agreement. The agreement, which begins with ... at FHU|Dickson. , The agreement allows students to be jointly admitted to ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016  Edwards Lifesciences Corporation (NYSE: EW ... heart disease and critical care monitoring, announced today that ... agreement with Morgan Stanley & Co. LLC to repurchase ... part of the Company,s previously authorized program to repurchase ... --> --> ...
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  Montoya Love ... Professional in the field of Pharmaceuticals. Montoya is the ... Manufacturing ... supplies, Becton Dickinson provides healthcare institutions, clinical ... equipment throughout fifty countries across the globe. ...
Breaking Medicine Technology: